Global DNA Polymerase

DNA Polymerase Comprehensive Study by Type (Prokaryotic DNA polymerase, Eukaryotic DNA polymerase), Application (DNA Cloning, SNP Analysis, Next Generation Sequencing Applications, Other), End-User (Molecular diagnostics companies, Diagnostic laboratories, Academic and research institutes, Biopharmaceutical companies, Hospitals) Players and Region - Global Market Outlook to 2028

DNA Polymerase Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About DNA Polymerase
DNA polymerase is a thermostable fusion polymerase made up of a Pyrococcus-like proofreading enzyme linked to the DNA-binding protein. It accurately amplifies lengthy products from a variety of DNA templates. For applications requiring great accuracy during DNA amplification, such as sequencing, cloning, or mutagenesis, high-fidelity PCR enzymes are used. Due to its greater efficacy in synthesising new DNA strands, DNA polymerase plays a critical role in diagnostic applications such as PCR assays. In order to apply PCR technology for biological applications, DNA polymerase is required. With the rising frequency of cancer, neurological illnesses, genetic mutations, and the rising number of chronic diseases, the DNA polymerase industry has a great potential for growth. The market for DNA polymerase will also develop as the number of recombinant medications for treating chronic diseases rises. The usage of DNA polymerase in forensic testing such as DNA fingerprinting will increase as crime levels rise around the world, propelling the market forward. One of the major factors driving the considerable rise of the high-fidelity DNA polymerase market is the increasing number of research and development activities. Other factors such as an increase in the number of research laboratories, more public awareness, and technical improvements are projected to boost the market for high-fidelity DNA polymerase. The market for high-fidelity DNA polymerase is predicted to rise as a result of government efforts and increased government financing for research and development.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States & Europe Players will contribute the maximum growth to Global DNA Polymerase market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Thermo Fisher Scientific (United States), Bio-Rad Laboratories Inc. (United States), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (United States), Analytik Jena AG (Switzerland), bioMérieux SA (France), Danaher Corporation (United States), Eppendorf (Germany), Fluidigm Corporation (United States) and Merck KGaA (Germany) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Molbio Diag. Pvt Ltd (India), Kilpest India Ltd(India) and Cosara Diagnostics Pvt. Ltd (India).

Segmentation Overview
AMA Research has segmented the market of Global DNA Polymerase market by Type (Prokaryotic DNA polymerase and Eukaryotic DNA polymerase), Application (DNA Cloning, SNP Analysis, Next Generation Sequencing Applications and Other) and Region.



On the basis of geography, the market of DNA Polymerase has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End-User, the sub-segment i.e. Molecular diagnostics companies will boost the DNA Polymerase market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
New Protein Engineering Techniques are Being Used to Generate Artificial Or Mutant DNA Polymerases

Market Growth Drivers:
Rapidly Increasing Use of DNA Polymerases in Molecular Diagnostics and Increasing Applications of DNA Polymerases in the Field of Epigenetics Research

Restraints:
High Cost of Reagents and Availability of Relatively Affordable Alternative Techniques

Opportunities:
Increasing Number of Research and Developmental Activities and Increased Investment and Technological Advancements

Market Leaders and their expansionary development strategies
In July 2023, Applied DNA Sciences, Inc., a leader in PCR-based DNA technologies, has acquired Spindle Biotech Inc, an early-stage, private biotech company developing next-generation RNA manufacturing technologies. The acquisition uniquely leverages the Company's LinearDNA™ platform that enables the efficient chemical modification of DNA templates and the high binding affinity of Spindle's proprietary, high-performance RNA polymerase (RNAP) for chemically modified DNA templates to deliver multiple advantages over conventional plasmid DNA-based mRNA production
In August 2023, ArcticZymes Technologies (AZT) has launch of its new product, AZtaq™ DNA Polymerase. AZtaq™ is a high-quality thermostable DNA polymerase suitable for use in polymerase chain reaction (PCR) applications. Launching the AZtaq™ is a natural expansion of the Company’s molecular tools portfolio. Being an essential enzyme in PCR, the thermostable DNA polymerase plays a pivotal role and enables numerous applications within molecular diagnostics and research.


Key Target Audience
Molecular Diagnostics Companies, Diagnostic Laboratories, Academic and Research Institutes, Biopharmaceutical Companies, Hospitals and Governmental Bodies

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Prokaryotic DNA polymerase
  • Eukaryotic DNA polymerase
By Application
  • DNA Cloning
  • SNP Analysis
  • Next Generation Sequencing Applications
  • Other
By End-User
  • Molecular diagnostics companies
  • Diagnostic laboratories
  • Academic and research institutes
  • Biopharmaceutical companies
  • Hospitals

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rapidly Increasing Use of DNA Polymerases in Molecular Diagnostics
      • 3.2.2. Increasing Applications of DNA Polymerases in the Field of Epigenetics Research
    • 3.3. Market Trends
      • 3.3.1. New Protein Engineering Techniques are Being Used to Generate Artificial Or Mutant DNA Polymerases
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global DNA Polymerase, by Type, Application, End-User and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global DNA Polymerase (Value)
      • 5.2.1. Global DNA Polymerase by: Type (Value)
        • 5.2.1.1. Prokaryotic DNA polymerase
        • 5.2.1.2. Eukaryotic DNA polymerase
      • 5.2.2. Global DNA Polymerase by: Application (Value)
        • 5.2.2.1. DNA Cloning
        • 5.2.2.2. SNP Analysis
        • 5.2.2.3. Next Generation Sequencing Applications
        • 5.2.2.4. Other
      • 5.2.3. Global DNA Polymerase by: End-User (Value)
        • 5.2.3.1. Molecular diagnostics companies
        • 5.2.3.2. Diagnostic laboratories
        • 5.2.3.3. Academic and research institutes
        • 5.2.3.4. Biopharmaceutical companies
        • 5.2.3.5. Hospitals
      • 5.2.4. Global DNA Polymerase Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. DNA Polymerase: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bio-Rad Laboratories Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. F. Hoffmann-La Roche Ltd. (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Abbott Laboratories (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Analytik Jena AG (Switzerland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. BioMérieux SA (France)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Danaher Corporation (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Eppendorf (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Fluidigm Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Merck KGaA (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global DNA Polymerase Sale, by Type, Application, End-User and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global DNA Polymerase (Value)
      • 7.2.1. Global DNA Polymerase by: Type (Value)
        • 7.2.1.1. Prokaryotic DNA polymerase
        • 7.2.1.2. Eukaryotic DNA polymerase
      • 7.2.2. Global DNA Polymerase by: Application (Value)
        • 7.2.2.1. DNA Cloning
        • 7.2.2.2. SNP Analysis
        • 7.2.2.3. Next Generation Sequencing Applications
        • 7.2.2.4. Other
      • 7.2.3. Global DNA Polymerase by: End-User (Value)
        • 7.2.3.1. Molecular diagnostics companies
        • 7.2.3.2. Diagnostic laboratories
        • 7.2.3.3. Academic and research institutes
        • 7.2.3.4. Biopharmaceutical companies
        • 7.2.3.5. Hospitals
      • 7.2.4. Global DNA Polymerase Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. DNA Polymerase: by Type(USD Million)
  • Table 2. DNA Polymerase Prokaryotic DNA polymerase , by Region USD Million (2017-2022)
  • Table 3. DNA Polymerase Eukaryotic DNA polymerase , by Region USD Million (2017-2022)
  • Table 4. DNA Polymerase: by Application(USD Million)
  • Table 5. DNA Polymerase DNA Cloning , by Region USD Million (2017-2022)
  • Table 6. DNA Polymerase SNP Analysis , by Region USD Million (2017-2022)
  • Table 7. DNA Polymerase Next Generation Sequencing Applications , by Region USD Million (2017-2022)
  • Table 8. DNA Polymerase Other , by Region USD Million (2017-2022)
  • Table 9. DNA Polymerase: by End-User(USD Million)
  • Table 10. DNA Polymerase Molecular diagnostics companies , by Region USD Million (2017-2022)
  • Table 11. DNA Polymerase Diagnostic laboratories , by Region USD Million (2017-2022)
  • Table 12. DNA Polymerase Academic and research institutes , by Region USD Million (2017-2022)
  • Table 13. DNA Polymerase Biopharmaceutical companies , by Region USD Million (2017-2022)
  • Table 14. DNA Polymerase Hospitals , by Region USD Million (2017-2022)
  • Table 15. South America DNA Polymerase, by Country USD Million (2017-2022)
  • Table 16. South America DNA Polymerase, by Type USD Million (2017-2022)
  • Table 17. South America DNA Polymerase, by Application USD Million (2017-2022)
  • Table 18. South America DNA Polymerase, by End-User USD Million (2017-2022)
  • Table 19. Brazil DNA Polymerase, by Type USD Million (2017-2022)
  • Table 20. Brazil DNA Polymerase, by Application USD Million (2017-2022)
  • Table 21. Brazil DNA Polymerase, by End-User USD Million (2017-2022)
  • Table 22. Argentina DNA Polymerase, by Type USD Million (2017-2022)
  • Table 23. Argentina DNA Polymerase, by Application USD Million (2017-2022)
  • Table 24. Argentina DNA Polymerase, by End-User USD Million (2017-2022)
  • Table 25. Rest of South America DNA Polymerase, by Type USD Million (2017-2022)
  • Table 26. Rest of South America DNA Polymerase, by Application USD Million (2017-2022)
  • Table 27. Rest of South America DNA Polymerase, by End-User USD Million (2017-2022)
  • Table 28. Asia Pacific DNA Polymerase, by Country USD Million (2017-2022)
  • Table 29. Asia Pacific DNA Polymerase, by Type USD Million (2017-2022)
  • Table 30. Asia Pacific DNA Polymerase, by Application USD Million (2017-2022)
  • Table 31. Asia Pacific DNA Polymerase, by End-User USD Million (2017-2022)
  • Table 32. China DNA Polymerase, by Type USD Million (2017-2022)
  • Table 33. China DNA Polymerase, by Application USD Million (2017-2022)
  • Table 34. China DNA Polymerase, by End-User USD Million (2017-2022)
  • Table 35. Japan DNA Polymerase, by Type USD Million (2017-2022)
  • Table 36. Japan DNA Polymerase, by Application USD Million (2017-2022)
  • Table 37. Japan DNA Polymerase, by End-User USD Million (2017-2022)
  • Table 38. India DNA Polymerase, by Type USD Million (2017-2022)
  • Table 39. India DNA Polymerase, by Application USD Million (2017-2022)
  • Table 40. India DNA Polymerase, by End-User USD Million (2017-2022)
  • Table 41. South Korea DNA Polymerase, by Type USD Million (2017-2022)
  • Table 42. South Korea DNA Polymerase, by Application USD Million (2017-2022)
  • Table 43. South Korea DNA Polymerase, by End-User USD Million (2017-2022)
  • Table 44. Taiwan DNA Polymerase, by Type USD Million (2017-2022)
  • Table 45. Taiwan DNA Polymerase, by Application USD Million (2017-2022)
  • Table 46. Taiwan DNA Polymerase, by End-User USD Million (2017-2022)
  • Table 47. Australia DNA Polymerase, by Type USD Million (2017-2022)
  • Table 48. Australia DNA Polymerase, by Application USD Million (2017-2022)
  • Table 49. Australia DNA Polymerase, by End-User USD Million (2017-2022)
  • Table 50. Rest of Asia-Pacific DNA Polymerase, by Type USD Million (2017-2022)
  • Table 51. Rest of Asia-Pacific DNA Polymerase, by Application USD Million (2017-2022)
  • Table 52. Rest of Asia-Pacific DNA Polymerase, by End-User USD Million (2017-2022)
  • Table 53. Europe DNA Polymerase, by Country USD Million (2017-2022)
  • Table 54. Europe DNA Polymerase, by Type USD Million (2017-2022)
  • Table 55. Europe DNA Polymerase, by Application USD Million (2017-2022)
  • Table 56. Europe DNA Polymerase, by End-User USD Million (2017-2022)
  • Table 57. Germany DNA Polymerase, by Type USD Million (2017-2022)
  • Table 58. Germany DNA Polymerase, by Application USD Million (2017-2022)
  • Table 59. Germany DNA Polymerase, by End-User USD Million (2017-2022)
  • Table 60. France DNA Polymerase, by Type USD Million (2017-2022)
  • Table 61. France DNA Polymerase, by Application USD Million (2017-2022)
  • Table 62. France DNA Polymerase, by End-User USD Million (2017-2022)
  • Table 63. Italy DNA Polymerase, by Type USD Million (2017-2022)
  • Table 64. Italy DNA Polymerase, by Application USD Million (2017-2022)
  • Table 65. Italy DNA Polymerase, by End-User USD Million (2017-2022)
  • Table 66. United Kingdom DNA Polymerase, by Type USD Million (2017-2022)
  • Table 67. United Kingdom DNA Polymerase, by Application USD Million (2017-2022)
  • Table 68. United Kingdom DNA Polymerase, by End-User USD Million (2017-2022)
  • Table 69. Netherlands DNA Polymerase, by Type USD Million (2017-2022)
  • Table 70. Netherlands DNA Polymerase, by Application USD Million (2017-2022)
  • Table 71. Netherlands DNA Polymerase, by End-User USD Million (2017-2022)
  • Table 72. Rest of Europe DNA Polymerase, by Type USD Million (2017-2022)
  • Table 73. Rest of Europe DNA Polymerase, by Application USD Million (2017-2022)
  • Table 74. Rest of Europe DNA Polymerase, by End-User USD Million (2017-2022)
  • Table 75. MEA DNA Polymerase, by Country USD Million (2017-2022)
  • Table 76. MEA DNA Polymerase, by Type USD Million (2017-2022)
  • Table 77. MEA DNA Polymerase, by Application USD Million (2017-2022)
  • Table 78. MEA DNA Polymerase, by End-User USD Million (2017-2022)
  • Table 79. Middle East DNA Polymerase, by Type USD Million (2017-2022)
  • Table 80. Middle East DNA Polymerase, by Application USD Million (2017-2022)
  • Table 81. Middle East DNA Polymerase, by End-User USD Million (2017-2022)
  • Table 82. Africa DNA Polymerase, by Type USD Million (2017-2022)
  • Table 83. Africa DNA Polymerase, by Application USD Million (2017-2022)
  • Table 84. Africa DNA Polymerase, by End-User USD Million (2017-2022)
  • Table 85. North America DNA Polymerase, by Country USD Million (2017-2022)
  • Table 86. North America DNA Polymerase, by Type USD Million (2017-2022)
  • Table 87. North America DNA Polymerase, by Application USD Million (2017-2022)
  • Table 88. North America DNA Polymerase, by End-User USD Million (2017-2022)
  • Table 89. United States DNA Polymerase, by Type USD Million (2017-2022)
  • Table 90. United States DNA Polymerase, by Application USD Million (2017-2022)
  • Table 91. United States DNA Polymerase, by End-User USD Million (2017-2022)
  • Table 92. Canada DNA Polymerase, by Type USD Million (2017-2022)
  • Table 93. Canada DNA Polymerase, by Application USD Million (2017-2022)
  • Table 94. Canada DNA Polymerase, by End-User USD Million (2017-2022)
  • Table 95. Mexico DNA Polymerase, by Type USD Million (2017-2022)
  • Table 96. Mexico DNA Polymerase, by Application USD Million (2017-2022)
  • Table 97. Mexico DNA Polymerase, by End-User USD Million (2017-2022)
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. DNA Polymerase: by Type(USD Million)
  • Table 109. DNA Polymerase Prokaryotic DNA polymerase , by Region USD Million (2023-2028)
  • Table 110. DNA Polymerase Eukaryotic DNA polymerase , by Region USD Million (2023-2028)
  • Table 111. DNA Polymerase: by Application(USD Million)
  • Table 112. DNA Polymerase DNA Cloning , by Region USD Million (2023-2028)
  • Table 113. DNA Polymerase SNP Analysis , by Region USD Million (2023-2028)
  • Table 114. DNA Polymerase Next Generation Sequencing Applications , by Region USD Million (2023-2028)
  • Table 115. DNA Polymerase Other , by Region USD Million (2023-2028)
  • Table 116. DNA Polymerase: by End-User(USD Million)
  • Table 117. DNA Polymerase Molecular diagnostics companies , by Region USD Million (2023-2028)
  • Table 118. DNA Polymerase Diagnostic laboratories , by Region USD Million (2023-2028)
  • Table 119. DNA Polymerase Academic and research institutes , by Region USD Million (2023-2028)
  • Table 120. DNA Polymerase Biopharmaceutical companies , by Region USD Million (2023-2028)
  • Table 121. DNA Polymerase Hospitals , by Region USD Million (2023-2028)
  • Table 122. South America DNA Polymerase, by Country USD Million (2023-2028)
  • Table 123. South America DNA Polymerase, by Type USD Million (2023-2028)
  • Table 124. South America DNA Polymerase, by Application USD Million (2023-2028)
  • Table 125. South America DNA Polymerase, by End-User USD Million (2023-2028)
  • Table 126. Brazil DNA Polymerase, by Type USD Million (2023-2028)
  • Table 127. Brazil DNA Polymerase, by Application USD Million (2023-2028)
  • Table 128. Brazil DNA Polymerase, by End-User USD Million (2023-2028)
  • Table 129. Argentina DNA Polymerase, by Type USD Million (2023-2028)
  • Table 130. Argentina DNA Polymerase, by Application USD Million (2023-2028)
  • Table 131. Argentina DNA Polymerase, by End-User USD Million (2023-2028)
  • Table 132. Rest of South America DNA Polymerase, by Type USD Million (2023-2028)
  • Table 133. Rest of South America DNA Polymerase, by Application USD Million (2023-2028)
  • Table 134. Rest of South America DNA Polymerase, by End-User USD Million (2023-2028)
  • Table 135. Asia Pacific DNA Polymerase, by Country USD Million (2023-2028)
  • Table 136. Asia Pacific DNA Polymerase, by Type USD Million (2023-2028)
  • Table 137. Asia Pacific DNA Polymerase, by Application USD Million (2023-2028)
  • Table 138. Asia Pacific DNA Polymerase, by End-User USD Million (2023-2028)
  • Table 139. China DNA Polymerase, by Type USD Million (2023-2028)
  • Table 140. China DNA Polymerase, by Application USD Million (2023-2028)
  • Table 141. China DNA Polymerase, by End-User USD Million (2023-2028)
  • Table 142. Japan DNA Polymerase, by Type USD Million (2023-2028)
  • Table 143. Japan DNA Polymerase, by Application USD Million (2023-2028)
  • Table 144. Japan DNA Polymerase, by End-User USD Million (2023-2028)
  • Table 145. India DNA Polymerase, by Type USD Million (2023-2028)
  • Table 146. India DNA Polymerase, by Application USD Million (2023-2028)
  • Table 147. India DNA Polymerase, by End-User USD Million (2023-2028)
  • Table 148. South Korea DNA Polymerase, by Type USD Million (2023-2028)
  • Table 149. South Korea DNA Polymerase, by Application USD Million (2023-2028)
  • Table 150. South Korea DNA Polymerase, by End-User USD Million (2023-2028)
  • Table 151. Taiwan DNA Polymerase, by Type USD Million (2023-2028)
  • Table 152. Taiwan DNA Polymerase, by Application USD Million (2023-2028)
  • Table 153. Taiwan DNA Polymerase, by End-User USD Million (2023-2028)
  • Table 154. Australia DNA Polymerase, by Type USD Million (2023-2028)
  • Table 155. Australia DNA Polymerase, by Application USD Million (2023-2028)
  • Table 156. Australia DNA Polymerase, by End-User USD Million (2023-2028)
  • Table 157. Rest of Asia-Pacific DNA Polymerase, by Type USD Million (2023-2028)
  • Table 158. Rest of Asia-Pacific DNA Polymerase, by Application USD Million (2023-2028)
  • Table 159. Rest of Asia-Pacific DNA Polymerase, by End-User USD Million (2023-2028)
  • Table 160. Europe DNA Polymerase, by Country USD Million (2023-2028)
  • Table 161. Europe DNA Polymerase, by Type USD Million (2023-2028)
  • Table 162. Europe DNA Polymerase, by Application USD Million (2023-2028)
  • Table 163. Europe DNA Polymerase, by End-User USD Million (2023-2028)
  • Table 164. Germany DNA Polymerase, by Type USD Million (2023-2028)
  • Table 165. Germany DNA Polymerase, by Application USD Million (2023-2028)
  • Table 166. Germany DNA Polymerase, by End-User USD Million (2023-2028)
  • Table 167. France DNA Polymerase, by Type USD Million (2023-2028)
  • Table 168. France DNA Polymerase, by Application USD Million (2023-2028)
  • Table 169. France DNA Polymerase, by End-User USD Million (2023-2028)
  • Table 170. Italy DNA Polymerase, by Type USD Million (2023-2028)
  • Table 171. Italy DNA Polymerase, by Application USD Million (2023-2028)
  • Table 172. Italy DNA Polymerase, by End-User USD Million (2023-2028)
  • Table 173. United Kingdom DNA Polymerase, by Type USD Million (2023-2028)
  • Table 174. United Kingdom DNA Polymerase, by Application USD Million (2023-2028)
  • Table 175. United Kingdom DNA Polymerase, by End-User USD Million (2023-2028)
  • Table 176. Netherlands DNA Polymerase, by Type USD Million (2023-2028)
  • Table 177. Netherlands DNA Polymerase, by Application USD Million (2023-2028)
  • Table 178. Netherlands DNA Polymerase, by End-User USD Million (2023-2028)
  • Table 179. Rest of Europe DNA Polymerase, by Type USD Million (2023-2028)
  • Table 180. Rest of Europe DNA Polymerase, by Application USD Million (2023-2028)
  • Table 181. Rest of Europe DNA Polymerase, by End-User USD Million (2023-2028)
  • Table 182. MEA DNA Polymerase, by Country USD Million (2023-2028)
  • Table 183. MEA DNA Polymerase, by Type USD Million (2023-2028)
  • Table 184. MEA DNA Polymerase, by Application USD Million (2023-2028)
  • Table 185. MEA DNA Polymerase, by End-User USD Million (2023-2028)
  • Table 186. Middle East DNA Polymerase, by Type USD Million (2023-2028)
  • Table 187. Middle East DNA Polymerase, by Application USD Million (2023-2028)
  • Table 188. Middle East DNA Polymerase, by End-User USD Million (2023-2028)
  • Table 189. Africa DNA Polymerase, by Type USD Million (2023-2028)
  • Table 190. Africa DNA Polymerase, by Application USD Million (2023-2028)
  • Table 191. Africa DNA Polymerase, by End-User USD Million (2023-2028)
  • Table 192. North America DNA Polymerase, by Country USD Million (2023-2028)
  • Table 193. North America DNA Polymerase, by Type USD Million (2023-2028)
  • Table 194. North America DNA Polymerase, by Application USD Million (2023-2028)
  • Table 195. North America DNA Polymerase, by End-User USD Million (2023-2028)
  • Table 196. United States DNA Polymerase, by Type USD Million (2023-2028)
  • Table 197. United States DNA Polymerase, by Application USD Million (2023-2028)
  • Table 198. United States DNA Polymerase, by End-User USD Million (2023-2028)
  • Table 199. Canada DNA Polymerase, by Type USD Million (2023-2028)
  • Table 200. Canada DNA Polymerase, by Application USD Million (2023-2028)
  • Table 201. Canada DNA Polymerase, by End-User USD Million (2023-2028)
  • Table 202. Mexico DNA Polymerase, by Type USD Million (2023-2028)
  • Table 203. Mexico DNA Polymerase, by Application USD Million (2023-2028)
  • Table 204. Mexico DNA Polymerase, by End-User USD Million (2023-2028)
  • Table 205. Research Programs/Design for This Report
  • Table 206. Key Data Information from Secondary Sources
  • Table 207. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global DNA Polymerase: by Type USD Million (2017-2022)
  • Figure 5. Global DNA Polymerase: by Application USD Million (2017-2022)
  • Figure 6. Global DNA Polymerase: by End-User USD Million (2017-2022)
  • Figure 7. South America DNA Polymerase Share (%), by Country
  • Figure 8. Asia Pacific DNA Polymerase Share (%), by Country
  • Figure 9. Europe DNA Polymerase Share (%), by Country
  • Figure 10. MEA DNA Polymerase Share (%), by Country
  • Figure 11. North America DNA Polymerase Share (%), by Country
  • Figure 12. Global DNA Polymerase share by Players 2022 (%)
  • Figure 13. Global DNA Polymerase share by Players (Top 3) 2022(%)
  • Figure 14. Global DNA Polymerase share by Players (Top 5) 2022(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 17. Thermo Fisher Scientific (United States) Revenue: by Geography 2022
  • Figure 18. Bio-Rad Laboratories Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Bio-Rad Laboratories Inc. (United States) Revenue: by Geography 2022
  • Figure 20. F. Hoffmann-La Roche Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 21. F. Hoffmann-La Roche Ltd. (Switzerland) Revenue: by Geography 2022
  • Figure 22. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 23. Abbott Laboratories (United States) Revenue: by Geography 2022
  • Figure 24. Analytik Jena AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 25. Analytik Jena AG (Switzerland) Revenue: by Geography 2022
  • Figure 26. BioMérieux SA (France) Revenue, Net Income and Gross profit
  • Figure 27. BioMérieux SA (France) Revenue: by Geography 2022
  • Figure 28. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 29. Danaher Corporation (United States) Revenue: by Geography 2022
  • Figure 30. Eppendorf (Germany) Revenue, Net Income and Gross profit
  • Figure 31. Eppendorf (Germany) Revenue: by Geography 2022
  • Figure 32. Fluidigm Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 33. Fluidigm Corporation (United States) Revenue: by Geography 2022
  • Figure 34. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 35. Merck KGaA (Germany) Revenue: by Geography 2022
  • Figure 36. Global DNA Polymerase: by Type USD Million (2023-2028)
  • Figure 37. Global DNA Polymerase: by Application USD Million (2023-2028)
  • Figure 38. Global DNA Polymerase: by End-User USD Million (2023-2028)
  • Figure 39. South America DNA Polymerase Share (%), by Country
  • Figure 40. Asia Pacific DNA Polymerase Share (%), by Country
  • Figure 41. Europe DNA Polymerase Share (%), by Country
  • Figure 42. MEA DNA Polymerase Share (%), by Country
  • Figure 43. North America DNA Polymerase Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Thermo Fisher Scientific (United States)
  • Bio-Rad Laboratories Inc. (United States)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Abbott Laboratories (United States)
  • Analytik Jena AG (Switzerland)
  • bioMérieux SA (France)
  • Danaher Corporation (United States)
  • Eppendorf (Germany)
  • Fluidigm Corporation (United States)
  • Merck KGaA (Germany)
Additional players considered in the study are as follows:
Molbio Diag. Pvt Ltd (India) , Kilpest India Ltd(India) , Cosara Diagnostics Pvt. Ltd (India)
Select User Access Type

Key Highlights of Report


Dec 2023 244 Pages 89 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global DNA Polymerase Quantitative research analysis
Global DNA Polymerase Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Thermo Fisher Scientific (United States), Bio-Rad Laboratories Inc. (United States), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (United States), Analytik Jena AG (Switzerland), bioMérieux SA (France), Danaher Corporation (United States), Eppendorf (Germany), Fluidigm Corporation (United States) and Merck KGaA (Germany) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"New Protein Engineering Techniques are Being Used to Generate Artificial Or Mutant DNA Polymerases" is seen as one of major influencing trends for DNA Polymerase Market during projected period 2022-2028.
The DNA Polymerase market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global DNA Polymerase Report?

Have a Query? Click Here

Other Related Reports

Hepcidin Comprehensive Study by Type (DS-79182026, M-009, PRS-080, PTG-300, Others), Application (Acute Inflammation, Anemia, Iron Deficiency Anemia, Sickle Cell Disease, Others), End-Use (Hospitals,...
$ 3450
Stem Cell Antibody Comprehensive Study by Type (Primary Antibodies, Secondary Antibodies), Application (Developmental biology, Disease modeling research, Drug development screening, Cell therapy stud...
$ 3750
Transfection Reagents Comprehensive Study by Type (Reagents, Instruments), Application (Biomedical Research, Gene Expression Studies, Cancer Research, Transgenic Model, Protein Production, Therapeuti...
$ 3750
Radiopharmaceuticals in Nuclear Medicine Comprehensive Study by Type (Diagnostic Nuclear Medicine (PECT Radiopharmaceuticals, PET Radiopharmaceuticals), Therapeutic Nuclear Medicine (Alpha Emitters, ...
$ 3750
Cosmetic Implants Comprehensive Study by Type (Breast Implants, Dental Implants, Facial Implants, Others), Application (Hospital, Cosmetic Club), Material (Polymers, Metal Implants, Bio Material, Cer...
$ 3500
Slide Stainer Comprehensive Study by Type (Reagent, Equipment {Automated, Manual}, Consumables & Accessories), End User (Hospitals and Diagnostic Laboratories, Academic and Research Institutes, Phar...
$ 3750